338: Chinese biotechs, a WHO departure, and post-JPM thoughts
The Readout Loud
00:00
Shifting Dynamics in Drug Development: The Rise of Chinese Biotechs
This chapter examines the growing prominence of the Chinese biotech industry in drug development, underlining investor interest and competitive pressures. It also highlights a strategic shift in how pharmaceutical companies approach licensing and collaborations with drug candidates.
Transcript
Play full episode
